• Explore /
  • Poster
  • / FOENIX-CCA2 quality of life data for futibatinib-treated intrahepatic cholangiocarcinoma (iCCA) patients with <em>FGFR2</em> fusions/rearrangements.

FOENIX-CCA2 quality of life data for futibatinib-treated intrahepatic cholangiocarcinoma (iCCA) patients with FGFR2 fusions/rearrangements.

Abstract Video & Slides Poster

Authors

null

Juan W. Valle

University of Manchester, The Christie NHS Foundation Trust, Manchester, United Kingdom

Juan W. Valle , Antoine Hollebecque , Junji Furuse , Lipika Goyal , Funda Meric-Bernstam , Robert S. Epstein , Tehseen Salimi , Volker Wacheck , Mei Liu , Karim A. Benhadji , John A. Bridgewater

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2021 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Track

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Sub Track

Hepatobiliary Cancer

Clinical Trial Registration Number

NCT02052778

Citation

J Clin Oncol 39, 2021 (suppl 15; abstr 4097)

DOI

10.1200/JCO.2021.39.15_suppl.4097

Abstract #

4097

Poster Bd #

Online Only

Abstract Disclosures

Similar Posters

Poster

2019 Gastrointestinal Cancers Symposium

FOENIX-101: A phase II trial of TAS-120 in patients with intrahepatic cholangiocarcinoma harboring <em>FGFR2</em> gene rearrangements.

FOENIX-101: A phase II trial of TAS-120 in patients with intrahepatic cholangiocarcinoma harboring FGFR2 gene rearrangements.

First Author: Lipika Goyal

First Author: Ignacio Duran

First Author: Shishir K. Maithel

First Author: Brett S Walker